| - GRCh37:
- Chr10:50740989
- GRCh38:
- Chr10:49532943
| ERCC6, ERCC6-PGBD3 | H8fs | DE SANCTIS-CACCHIONE SYNDROME, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
| Pathogenic (Feb 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678747
- GRCh38:
- Chr10:49470701
| ERCC6 | R1087* | not provided, Cockayne syndrome type 2 | Pathogenic/Likely pathogenic (Nov 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:50681596
- GRCh38:
- Chr10:49473550
| ERCC6 | K879fs | Cockayne syndrome type 2 | Likely pathogenic (Jan 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50680464-50680465
- GRCh38:
- Chr10:49472418-49472419
| ERCC6, LOC126860933 | R961fs | Cockayne syndrome type 2 | Likely pathogenic (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50684335-50684336
- GRCh38:
- Chr10:49476289-49476290
| ERCC6 | D770fs | Cockayne syndrome type 2 | Likely pathogenic (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50690767-50690768
- GRCh38:
- Chr10:49482721-49482722
| ERCC6 | T712fs | Cockayne syndrome type 2 | Likely pathogenic (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678324
- GRCh38:
- Chr10:49470278
| ERCC6 | K1228* | Cockayne syndrome type 2 | Likely pathogenic (Dec 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50713988-50713989
- GRCh38:
- Chr10:49505942-49505943
| ERCC6 | S489fs | Cockayne syndrome type 2 | Likely pathogenic (Dec 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50680988
- GRCh38:
- Chr10:49472942
| ERCC6, LOC126860933 | Y932* | Cockayne syndrome type 2 | Likely pathogenic (Dec 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50690867
- GRCh38:
- Chr10:49482821
| ERCC6 | Q679* | Cockayne syndrome type 2 | Likely pathogenic (Dec 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50732302
- GRCh38:
- Chr10:49524256
| ERCC6, ERCC6-PGBD3, PGBD3 | E392* | Cockayne syndrome type 2 | Likely pathogenic (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50732160-50732169
- GRCh38:
- Chr10:49524114-49524123
| ERCC6, ERCC6-PGBD3, PGBD3 | A436fs | Cockayne syndrome type 2 | Likely pathogenic (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678328-50678329
- GRCh38:
- Chr10:49470282-49470283
| ERCC6 | V1226fs | Cockayne syndrome type 2 | Likely pathogenic (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50691470
- GRCh38:
- Chr10:49483424
| ERCC6 | Y638* | Cockayne syndrome type 2 | Likely pathogenic (Dec 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50691479
- GRCh38:
- Chr10:49483433
| ERCC6 | S636fs | Cockayne syndrome type 2 | Likely pathogenic (Dec 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678382-50678383
- GRCh38:
- Chr10:49470336-49470337
| ERCC6 | S1209fs | Cockayne syndrome type 2 | Likely pathogenic (May 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50732261-50732262
- GRCh38:
- Chr10:49524215-49524216
| ERCC6, ERCC6-PGBD3, PGBD3 | K405fs | Cockayne syndrome type 2 | Likely pathogenic (May 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50732436
- GRCh38:
- Chr10:49524390
| ERCC6-PGBD3, ERCC6 | G347fs | not provided, Cockayne syndrome type 2 | Pathogenic/Likely pathogenic (May 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:50679088-50679089
- GRCh38:
- Chr10:49471042-49471043
| ERCC6 | L1001fs | Cockayne syndrome type 2 | Likely pathogenic (Dec 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50701169
- GRCh38:
- Chr10:49493123
| ERCC6 | H605fs | Cockayne syndrome type 2 | Likely pathogenic (Apr 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678407-50678408
- GRCh38:
- Chr10:49470361-49470362
| ERCC6 | L1200fs | Cockayne syndrome type 2 | Likely pathogenic (Dec 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50738855
- GRCh38:
- Chr10:49530809
| ERCC6, ERCC6-PGBD3 | K152* | Cockayne syndrome type 2 | Likely pathogenic (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50732263
- GRCh38:
- Chr10:49524217
| PGBD3, ERCC6, ERCC6-PGBD3 | K405* | Cockayne syndrome type 2 | Likely pathogenic (Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50690796
- GRCh38:
- Chr10:49482750
| ERCC6 | F703fs | Cockayne syndrome type 2 | Likely pathogenic (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678771-50678772
- GRCh38:
- Chr10:49470725-49470726
| ERCC6 | E1079fs | Cockayne syndrome type 2 | Likely pathogenic (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50732322
- GRCh38:
- Chr10:49524276
| ERCC6, ERCC6-PGBD3, PGBD3 | D385fs | Cockayne syndrome type 2 | Likely pathogenic (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50738846
- GRCh38:
- Chr10:49530800
| ERCC6, ERCC6-PGBD3 | E155* | Cockayne syndrome type 2 | Likely pathogenic (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50732701
- GRCh38:
- Chr10:49524655
| ERCC6, ERCC6-PGBD3 | K259* | Cockayne syndrome type 2 | Likely pathogenic (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50732134
- GRCh38:
- Chr10:49524088
| ERCC6, ERCC6-PGBD3, PGBD3 | K448* | Cockayne syndrome type 2 | Likely pathogenic (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678237-50678238
- GRCh38:
- Chr10:49470191-49470192
| ERCC6 | K1258fs | Cockayne syndrome type 2 | Likely pathogenic (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678434-50678435
- GRCh38:
- Chr10:49470388-49470389
| ERCC6 | A1191fs | Cockayne syndrome type 2 | Likely pathogenic (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50690736
- GRCh38:
- Chr10:49482690
| ERCC6 | Q723fs | Cockayne syndrome type 2 | Likely pathogenic (Mar 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50701224-50701225
- GRCh38:
- Chr10:49493178-49493179
| ERCC6 | T587fs | Cockayne syndrome type 2 | Likely pathogenic (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678500-50678501
- GRCh38:
- Chr10:49470454-49470455
| ERCC6 | W1169fs | Cockayne syndrome type 2 | Likely pathogenic (Feb 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50736496
- GRCh38:
- Chr10:49528450
| ERCC6, ERCC6-PGBD3 | E207* | Cockayne syndrome type 2 | Likely pathogenic (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50732263-50732264
- GRCh38:
- Chr10:49524217-49524218
| ERCC6, ERCC6-PGBD3, PGBD3 | K405fs | Cockayne syndrome type 2 | Likely pathogenic (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678516-50678517
- GRCh38:
- Chr10:49470470-49470471
| ERCC6 | Q1164fs | Cockayne syndrome type 2 | Likely pathogenic (Feb 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50691458
- GRCh38:
- Chr10:49483412
| ERCC6 | Y642* | Cockayne syndrome type 2 | Likely pathogenic (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50701265
- GRCh38:
- Chr10:49493219
| ERCC6 | C573* | Cockayne syndrome type 2 | Likely pathogenic (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50682123
- GRCh38:
- Chr10:49474077
| ERCC6 | I850fs | Cockayne syndrome type 2 | Likely pathogenic (Jan 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50732201-50732202
- GRCh38:
- Chr10:49524155-49524156
| ERCC6, ERCC6-PGBD3, PGBD3 | D425fs | Cockayne syndrome type 2 | Likely pathogenic (Jan 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50691515-50691517
- GRCh38:
- Chr10:49483469-49483471
| ERCC6 | T623fs | Cockayne syndrome type 2 | Likely pathogenic (Jan 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678684
- GRCh38:
- Chr10:49470638
| ERCC6 | G1108* | Cockayne syndrome type 2 | Likely pathogenic (Jan 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50682121-50682124
- GRCh38:
- Chr10:49474075-49474078
| ERCC6 | K849fs | Cockayne syndrome type 2 | Likely pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50738766-50738767
- GRCh38:
- Chr10:49530720-49530721
| ERCC6, ERCC6-PGBD3 | E182fs | Cockayne syndrome type 2 | Likely pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50732626
- GRCh38:
- Chr10:49524580
| ERCC6 | E284* | not provided, Cockayne syndrome type 2 | Pathogenic (Mar 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:50690865
- GRCh38:
- Chr10:49482819
| ERCC6 | | not provided, Lung cancer, UV-sensitive syndrome 1, Premature ovarian failure 11, DE SANCTIS-CACCHIONE SYNDROME, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2, Age related macular degeneration 5 | Conflicting interpretations of pathogenicity (Sep 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:50668466
- GRCh38:
- Chr10:49460420
| ERCC6 | F1339L | Cerebrooculofacioskeletal syndrome 1, DE SANCTIS-CACCHIONE SYNDROME, Age related macular degeneration 5, Cockayne syndrome type 2, UV-sensitive syndrome 1, Lung cancer, Premature ovarian failure 11, not provided, not specified
| Uncertain significance (Dec 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:50681527
- GRCh38:
- Chr10:49473481
| ERCC6 | N902S | not provided, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2, UV-sensitive syndrome 1, Age related macular degeneration 5, Premature ovarian failure 11, Lung cancer, DE SANCTIS-CACCHIONE SYNDROME | Uncertain significance (Nov 23, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:50686474
- GRCh38:
- Chr10:49478428
| ERCC6 | I738L | Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2, DE SANCTIS-CACCHIONE SYNDROME, Lung cancer, UV-sensitive syndrome 1, Age related macular degeneration 5, Premature ovarian failure 11, Inborn genetic diseases, not provided, Cockayne syndrome type 2 | Conflicting interpretations of pathogenicity (Mar 6, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:50684307
- GRCh38:
- Chr10:49476261
| ERCC6 | F779fs | Cockayne syndrome type 2 | Likely pathogenic (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50732755
- GRCh38:
- Chr10:49524709
| ERCC6-PGBD3, ERCC6 | R241C | not provided, DE SANCTIS-CACCHIONE SYNDROME, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2, UV-sensitive syndrome 1, Age related macular degeneration 5, Premature ovarian failure 11, Lung cancer | Uncertain significance (Jun 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:50736463
- GRCh38:
- Chr10:49528417
| ERCC6, ERCC6-PGBD3 | E218K | Cockayne syndrome type 2 | Uncertain significance (Jun 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50684228
- GRCh38:
- Chr10:49476182
| ERCC6 | | UV-sensitive syndrome 1, not provided, Cockayne syndrome type 2, DE SANCTIS-CACCHIONE SYNDROME, Cerebrooculofacioskeletal syndrome 1 | Benign (Jul 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:50701164
- GRCh38:
- Chr10:49493118
| ERCC6 | K607M | not provided, Premature ovarian failure 11, Cerebrooculofacioskeletal syndrome 1, UV-sensitive syndrome 1, Lung cancer, Age related macular degeneration 5, Cockayne syndrome type 2, DE SANCTIS-CACCHIONE SYNDROME | Uncertain significance (May 30, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:50732672
- GRCh38:
- Chr10:49524626
| ERCC6, ERCC6-PGBD3 | | DE SANCTIS-CACCHIONE SYNDROME, Age related macular degeneration 5, UV-sensitive syndrome 1, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2, Lung cancer, Premature ovarian failure 11, not provided | Likely benign (Apr 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:50690808-50690809
- GRCh38:
- Chr10:49482762-49482763
| ERCC6 | T699fs | Cerebrooculofacioskeletal syndrome 1, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2, Premature ovarian failure 11, DE SANCTIS-CACCHIONE SYNDROME, UV-sensitive syndrome 1, Age related macular degeneration 5, Lung cancer, not provided
| Pathogenic (Sep 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:50691550
- Chr10:50701257
- GRCh38:
- Chr10:49483504
- Chr10:49493211
| ERCC6, ERCC6 | R612*, T576R | Cerebrooculofacioskeletal syndrome 1 | Pathogenic (May 31, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr10:50678249
- GRCh38:
- Chr10:49470203
| ERCC6 | E1253* | Cockayne syndrome type 2 | Likely pathogenic (Apr 23, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50736541
- GRCh38:
- Chr10:49528495
| ERCC6, ERCC6-PGBD3 | Q192* | not provided, Cockayne syndrome type 2 | Pathogenic/Likely pathogenic (Aug 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:50713940
- GRCh38:
- Chr10:49505894
| ERCC6 | K506* | Cockayne syndrome type 2 | Likely pathogenic (Jul 6, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50701207
- GRCh38:
- Chr10:49493161
| ERCC6 | R593* | Cockayne syndrome type 2 | Likely pathogenic (Dec 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50701168
- GRCh38:
- Chr10:49493122
| ERCC6 | K606* | Cockayne syndrome type 2 | Likely pathogenic (Feb 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50686485
- GRCh38:
- Chr10:49478439
| ERCC6 | L734* | Cockayne syndrome type 2 | Likely pathogenic (Dec 6, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50684263
- GRCh38:
- Chr10:49476217
| ERCC6 | Q794* | Cockayne syndrome type 2 | Likely pathogenic (Sep 7, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50682167
- GRCh38:
- Chr10:49474121
| ERCC6 | W835* | Cockayne syndrome type 2 | Likely pathogenic (Mar 31, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50682128
- GRCh38:
- Chr10:49474082
| ERCC6 | L848* | Cockayne syndrome type 2 | Likely pathogenic (Oct 24, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50682105
- GRCh38:
- Chr10:49474059
| ERCC6 | Q856* | Cockayne syndrome type 2 | Likely pathogenic (Mar 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50680977
- GRCh38:
- Chr10:49472931
| ERCC6, LOC126860933 | W936* | Cockayne syndrome type 2 | Likely pathogenic (May 7, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50680500
- GRCh38:
- Chr10:49472454
| ERCC6, LOC126860933 | W949* | Cockayne syndrome type 2 | Likely pathogenic (Dec 4, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50679084
- GRCh38:
- Chr10:49471038
| ERCC6 | E1003* | Cockayne syndrome type 2 | Likely pathogenic (Dec 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50679021
- GRCh38:
- Chr10:49470975
| ERCC6 | G1024* | Cockayne syndrome type 2 | Likely pathogenic (Dec 23, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678909
- GRCh38:
- Chr10:49470863
| ERCC6 | K1033* | Cockayne syndrome type 2 | Likely pathogenic (Dec 27, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678651
- GRCh38:
- Chr10:49470605
| ERCC6 | E1119* | Cockayne syndrome type 2 | Likely pathogenic (Jun 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678558
- GRCh38:
- Chr10:49470512
| ERCC6 | K1150* | Cockayne syndrome type 2 | Likely pathogenic (May 31, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678541
- GRCh38:
- Chr10:49470495
| ERCC6 | Y1155* | Cockayne syndrome type 2 | Likely pathogenic (Mar 3, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678462
- GRCh38:
- Chr10:49470416
| ERCC6 | K1182* | Cockayne syndrome type 2 | Likely pathogenic (May 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678432
- GRCh38:
- Chr10:49470386
| ERCC6 | E1192* | Cockayne syndrome type 2 | Likely pathogenic (Apr 27, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678369
- GRCh38:
- Chr10:49470323
| ERCC6 | R1213* | Cockayne syndrome type 2 | Likely pathogenic (Oct 24, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50678351
- GRCh38:
- Chr10:49470305
| ERCC6 | G1219* | Cockayne syndrome type 2 | Likely pathogenic (Aug 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50738765
- GRCh38:
- Chr10:49530719
| ERCC6-PGBD3, ERCC6 | | Cockayne syndrome type 2 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr10:50701310
- GRCh38:
- Chr10:49493264
| ERCC6 | | not provided, Age related macular degeneration 5, Cockayne syndrome type 2, Cerebrooculofacioskeletal syndrome 1 | Conflicting interpretations of pathogenicity (Sep 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:50669480
- GRCh38:
- Chr10:49461434
| ERCC6 | R1301C | not provided, Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2 | Uncertain significance (Aug 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:50666615
- GRCh38:
- Chr10:49458569
| ERCC6 | | Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50664321
- GRCh38:
- Chr10:49456275
| ERCC6 | | Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
| Uncertain significance (Mar 30, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50664259
- GRCh38:
- Chr10:49456213
| ERCC6 | | Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
| Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50663505
- GRCh38:
- Chr10:49455459
| ERCC6 | | Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50663495
- GRCh38:
- Chr10:49455449
| ERCC6 | | Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50732518
- GRCh38:
- Chr10:49524472
| ERCC6, ERCC6-PGBD3 | V320L | Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
| Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50662653
- GRCh38:
- Chr10:49454607
| ERCC6 | | Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
| Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50732239
- GRCh38:
- Chr10:49524193
| ERCC6, ERCC6-PGBD3, PGBD3 | R413W | not specified, not provided, Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2 | Uncertain significance (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:50666048
- GRCh38:
- Chr10:49458002
| ERCC6 | | Cerebrooculofacioskeletal syndrome 1, Age related macular degeneration 5, Cockayne syndrome type 2
| Conflicting interpretations of pathogenicity (Jan 13, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:50664830
- GRCh38:
- Chr10:49456784
| ERCC6 | | Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
| Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50664199
- GRCh38:
- Chr10:49456153
| ERCC6 | | Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50664181
- GRCh38:
- Chr10:49456135
| ERCC6 | | Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50738895
- GRCh38:
- Chr10:49530849
| ERCC6, ERCC6-PGBD3 | | not provided, Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2 | Conflicting interpretations of pathogenicity (Sep 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:50738893
- GRCh38:
- Chr10:49530847
| ERCC6, ERCC6-PGBD3 | | not provided, Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2 | Conflicting interpretations of pathogenicity (Sep 10, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:50738878
- GRCh38:
- Chr10:49530832
| ERCC6 | T144M | not provided, Age related macular degeneration 5, Cockayne syndrome type 2, Cerebrooculofacioskeletal syndrome 1 | Conflicting interpretations of pathogenicity (Oct 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:50663466
- GRCh38:
- Chr10:49455420
| ERCC6 | | Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
| Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:50663177
- GRCh38:
- Chr10:49455131
| ERCC6 | | Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |